| Date |
Event |
Presentation |
Speakers |
|
July 21, 2013
|
54th Annual Short Course on Medical and Experimental Mammalian Genetics
|
C hromosome Struc ture and Function
|
Jeanne Lawrence
|
|
|
|
Saturday, July 27 Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds
|
Arkhat Abzhanov
|
|
|
|
Friday, August 2 Reawakening Fetal Hemogl o bin for Therapy: An Old Problem with New Prospects
|
Stuart Orkin
|
|
May 31, 2013
|
ASCO Annual Meeting 2013
|
Optimizing the Role of Advanced Practice Professionals in Oncology Practice
|
Lawrence N. Shulman
|
|
|
|
Hot Pathways for Targeted Therapy of B-Cell Malignancies
|
James E. Bradner
|
|
|
|
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer
|
Ian E. Krop
|
|
|
|
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer
|
David Kwiatkowski
|
|
|
|
Cancer Stem Cells: A New and Better Target in Pediatric Oncology?
|
Scott A. Armstrong, George Daley
|
|
|
|
Reaping the Rewards of the Cancer Genome Atlas Project
|
Levi A Garraway
|
|
|
|
Improving Cancer Care through Health Information Technology: Ethics and Practicality
|
Lawrence N. Shulman
|
|
|
|
Education Sessions
|
Robert G Maki, Stephen T Sonis
|
|
|
|
Education Sessions
|
Deborah Schrag
|
|
|
|
Education Sessions
|
Tracy T Batchelor
|
|
|
|
Education Sessions
|
Michael B. Atkins, Jennifer A. Ligibel
|
|
|
|
Educations Sessions
|
Monica M. Bertagnolli
|
|
|
|
Education Sessions
|
Bruce E. Johnson, Elizabeth R. Gerstner
|
|
April 6, 2013
|
AACR Annual Meetings
|
EPIGENETIC TARGETS FOR CANCER
|
Anjana Rao, James E. Bradner
|
|
|
|
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN
|
Stuart H. Orkin
|
|
|
|
Blood-Based Molecular Analysis of Cancer
|
Daniel A Haber
|
|
|
|
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA
|
Joan S Brugge
|
|
|
|
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY
|
Leonard I. Zon
|
|
|
|
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA
|
Claude Lechene
|
|
|
|
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Scott A. Armstrong
|
|
|
|
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA
|
Timothy J Mitchison
|
|
|
|
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
|
Karen Cichowski
|
|
|
|
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Cameron W Brennan
|
|
|
|
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA
|
Stephen J Elledge
|
|
|
|
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA
|
Raju Kucherlapati
|
|
|
|
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA
|
Anthony G. Letai
|
|
|
|
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY
|
Kornelia Polyak
|
|
|
|
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
|
Jeannie T. Lee
|
|
|
|
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA
|
Glenn Dranoff
|
|
|
|
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA
|
Frank McKeon
|
|
|
|
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA
|
Matthew Smith
|
|
|
|
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Rakesh K Jain, William C Hahn
|
|
|
|
Avatar: Individualized Human Cancer Models in Mice
|
Kwok-Kin Wong
|
|
|
|
Next-Generation Therapeutic Modeling in Mice
|
Pier Paolo
|
|
|
|
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA
|
Levi A Garraway
|
|
|
|
Clinical Trials Based on Mutations versus Histology
|
William R Sellers, Lewis C Cantley
|
|
|
|
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH
|
Peter M Howley
|
|
|
|
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA
|
Kwok-Kin Wong
|
|
|
|
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Anthony G. Letai
|
|
|
|
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO
|
Omid C Farokhzad
|
|
|
|
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX
|
Scott A. Armstrong
|
|
|
|
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced
|
Lynda Chin
|
|
|
|
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA
|
James E. Bradner
|
|
|
|
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom
|
Nika N. Danial
|
|
|
|
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Raghu Kalluri
|
|
|
|
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA
|
Andrew Kung
|
|
|
|
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA
|
William G Kaelin
|
|
|
|
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY
|
Xandra O Breakefield
|
|
|
|
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA
|
Thomas A. Look
|
|
|
|
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA
|
Gregory L Verdine
|
|
|
|
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA
|
Andrea L Richardson
|
|
|
|
Cancer Omics Beyond the Genome
|
Sunney Xie
|
|
|
|
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA
|
Kornelia Polyak
|
|
|
|
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO
|
Tan Ince
|
|
|
|
WICR Career Mentoring Session
|
Joan S Brugge
|
|
July 15, 2012
|
53rd Annual Short Course on Medical and Experimental Mammalian Genetics
|
Evening Lecture | Title TBD
|
David Altshuler
|
|
|
|
Title TBD
|
Paul Ridker
|
|
|
|
Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds
|
Arkhat Abzhanov
|
|
March 25, 2012
|
ISA 2012 - XVI International Symposium on Atherosclerosis
|
Healthy Drinking an Important Component of Healthy Eating
|
Frank B. Hu
|
|
December 13, 2011
|
New Horizons in Cancer Research: Biology to Prevention to Therapy
|
Welcome and Opening Remarks
|
Judy Garber
|
|
|
|
Epigenetics of hormone dependence
|
Myles Brown
|
|
December 4, 2011
|
Update in Internal Medicine
|
Oncology: Challenging Cases with Your Participation
|
Lowell E Schnipper
|
|
|
|
Oncology Q & A
|
Lowell E Schnipper
|
|
|
|
Cancer: From Bench to Bedside
|
Lowell E Schnipper
|
|
|
|
Introduction and Welcome
|
Martin J Abrahamson
|
|
|
|
New Frontiers in Radiology
|
Jonathan B. Kruskal
|
|
|
|
Endocrinology Q & A
|
Martin J Abrahamson
|
|
|
|
Endocrinology: Challenging Cases with Your Participation
|
Martin J Abrahamson
|
|
|
|
Treatment of Type 2 Diabetes 2011: Advances, Challenges and Opportunities
|
Martin J Abrahamson
|
|
|
|
The Evaluation and Management of Common Disorders of the Knee
|
C. Christopher Smith
|
|
|
|
Panel Discussion
|
Martin J Abrahamson
|
|
|
|
Delivering Customer Service Excellence
|
Martin J Abrahamson
|
|
|
|
Hypertension 2011: Recent Trials and Rational Therapy
|
Gerald W. Smetana
|
|
September 30, 2011
|
Revisiting IBD Management: Dogmas to be Challenged
|
Wrap-up
|
Stuart Schreiber
|
|
|
|
Dogma 6 – Innovative treatments will offer a better outcome for patients with IBD
|
Stuart Schreiber
|
|
|
|
Can we slow down evolution from early to late CD?
|
Stuart Schreiber
|
|
March 1, 2011
|
"The Latest Advances in Liver Cancer Research:
From Basic Science to Therapeutics"
|
Session 3 | (title will be announced later)
|
Sonia Friedman
|
|
|
|
Sessions 3 | (title will be announced later)
|
Sonia Friedman
|
|
November 7, 2010
|
Ninth Annual International Conference on Frontiers in Cancer Prevention Research
|
PARP inhibitors: Early promise in breast and ovarian cancer prevention
|
Judy E Garber
|
|
|
|
Clinical trials in neurofibromatosis 1 and 2
|
Scott Plotkin
|
|
September 30, 2010
|
Third AACR Conference on The Science of Cancer Health Disparities
|
From genomics to personalized medicine in oncology
|
Levi A Garraway
|
|
|
|
Title to be announced
|
Deborah Schrag
|
|
July 15, 2010
|
Osteoporosis 2010: New Insights in Research, Diagnosis, and Clinical Care
|
Beyond BMD: Bone Quality and Bone Strength
|
Mary L. Bouxsein
|
|
|
|
Special Topics in Osteoporosis
|
Mary L. Bouxsein
|
|
June 6, 2010
|
The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities
|
Welcome and Keynote Session: Where is Molecular Epidemiology?
|
David J. Hunter
|
|
April 11, 2010
|
Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2)
|
* Multigene Families: Role in Immunity and Pathology | Big Horn B
|
Peter R. Preiser
|
|
January 22, 2010
|
2010 Gastrointestinal Cancers Symposium
|
General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: Prevention, Screening, and Diagnosis
|
Sapna Syngal
|
|
|
|
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy
|
Rakesh K Jain
|
|
|
|
Newer Radiation Techniques in the Treatment of Hepatobiliary and Pancreatic Cancers
|
Harvey J. Mamon
|
|
|
|
Advanced Imaging Techniques
|
Dushyant Sahani
|
|
|
|
Gastroenterologist
|
William R. Brugge
|
|
|
|
Advanced Imaging Techniques
|
Dushyant Sahani
|
|
October 1, 2009
|
6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO)
|
Case Presentation 1: Stage II
|
David Ryan
|
How We Rank